Ron Bell, Attorney offering important information about “Lipitor Diabetes”
09/30/2013 (press release: Ann Mulhern) // Albuquerque, NM, USA // Ann Mulhern
If you take Lipitor and developed Type 2 Diabetes Ron Bell wants you to know the current legal remedies underway.
In January 2012, a study published in the Archives of Internal Medicine identified a potential link between statin use in women and type 2 diabetes. The study involved a cohort of 161,808 female test subjects between the ages of 50 and 79 who participated in the Women’s Health Initiative. The research ultimately determined that women who took statins like Lipitor were nearly 50% more likely to be diagnosed with diabetes than women who did not. The authors of the study concluded that “statin use is associated with an
increased risk for [type 2 diabetes].”
The Archives of Internal Medicine research succeeds two other 2011 studies published in the Lancet and the Journal of the American College of Cardiology (JACC). The Lancet study was a meta-analysis of several other studies which identified a 9% increase in type 2 diabetes diagnoses among statin users. The JACC study focused specifically on Lipitor, and found that daily doses of the drug at 80 mg increased the diabetes risk by nearly 40% over a placebo.
Type 2 diabetes is characterized by high blood glucose and insulin deficiency. While the condition is often managed in its early stages by exercise and dietary changes, prescription medications are usually required as the disease progresses. In the United States, there are approximately 24 million people living with diabetes, about 90% of which are type 2. With prevalence rates doubling between 1990 and 2005, the
Centers for Disease Control and Prevention (CDC) has characterized the disease as a nationwide epidemic. Signs and symptoms of Lipitor diabetes may include:
• Increased thirst and frequent urination
• Increased hunger
• Weight loss
• Blurred vision
• Slow-healing sores or frequent infections
• Areas of darkened skin
In addition to type 2 diabetes, Lipitor may cause the following serious side effects:
• Muscle damage
• Kidney damage
• Kidney failure (also known as renal failure)
• Liver Failure
• Memory loss
If you have been diagnosed with having a low BMI and developed Type 2 Diabetes after you were prescribed Lipitor call the offices of Ron Bell at Bell, Hughes, Colemn PA. They can assess your case at no cost to you and dertermine if you have a case.
We have attorneys who focus their practice on Cases like this and have helped hundreds of individuals receive compensation for injuries and wrongful deaths. We are offering free case evaluations for all Lipitor-Diabetes claims.
Call Ron Bell at the Bell, Hughes, Coleman Firm in Albuquerque today to discuss your case.
Call (505) 242-7979 or email us at [email protected]
Ron Bell is a practicing attorney in New Mexico for more than 30 years. He primarily limits his practice to personal injury law. In August of 2008 Bell merged his firm with the Hughes Coleman firm from Nashville,TN. The new firm offers all types of injury litigation and representation.
Social Media Tags:Ron Bell, Personal Injury attorney, Diabetes, Type 2 Diabetes, Lipitor, Lipitor Diabetes, Legal services in New Mexico, Free personal Injury case evaluations, Free Lipitor Diabetes case evaluations, Low body mass index diabetes and lipitor, lipitor causes diabetes, Pfizer Pharmaceuticals Lipitor.
Newsroom powered by Online Press Release Distribution – SubmitMyPressRelease.com
Other News / Press Releases
- Cardiologist accused of attempting to have rival doctor killed
- Former Daimler worker files lawsuit alleging discrimination
- Twitter Accused of Gender Bias in Discrimination Lawsuit
- Senator calls extended Gulf oil leak ‘unacceptable’
- Driver crashes into L.A. Times building, becomes injured
- Former NFL player convicted of murder
- Lamborghini and Ferrari crash in Beijing
- Indiana HIV outbreak passes 100 confirmed cases
- Suicide note of transgender teen gets attention of White House
- Justice Department announces charges against former e-commerce executive